Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1982 Nov;70(5):965–977. doi: 10.1172/JCI110708

Somatotroph Hyperplasia

SUCCESSFUL TREATMENT OF ACROMEGALY BY REMOVAL OF A PANCREATIC ISLET TUMOR SECRETING A GROWTH HORMONE-RELEASING FACTOR

M O Thorner 1,2,3,4,5,6, R L Perryman 1,2,3,4,5,6, M J Cronin 1,2,3,4,5,6, A D Rogol 1,2,3,4,5,6, M Draznin 1,2,3,4,5,6, A Johanson 1,2,3,4,5,6, W Vale 1,2,3,4,5,6, E Horvath 1,2,3,4,5,6, K Kovacs 1,2,3,4,5,6
PMCID: PMC370309  PMID: 6290540

Abstract

A 21-yr-old woman with Turner's syndrome presented with signs and symptoms of acromegaly. The serum growth hormone (GH) (95±9.4 ng/ml; mean±SEM) and somatomedin C (11 U/ml) levels were elevated, and an increase in GH levels after glucose instead of normal suppression, increase after thyrotropin-releasing hormone (TRH) administration instead of no change, and decrease after dopamine administration instead of stimulation were observed. The pituitary fossa volume was greater than normal (1,440 mm3) and the presence of a pituitary tumor was assumed. After tissue removal at transsphenoidal surgery, histological study revealed somatotroph hyperplasia rather than a discrete adenoma. Postoperatively, she remained clinically acromegalic and continued to show increased GH and somatomedin levels. A search was made for ectopic source of a growth hormone-releasing factor (GRF). Computer tomographic scan revealed a 5-cm Diam tumor in the tail of the pancreas. Following removal of this tumor, serum GH fell from 70 to 3 ng/ml over 2 h, and remained low for the subsequent 5 mo. Serum somatomedin C levels fell from 7.2 to normal by 6 wk postoperatively. There were no longer paradoxical GH responses to glucose, TRH, and dopamine. Both the medium that held the tumor cells at surgery and extracts of the tumor contained a peptide with GRF activity. The GRF contained in the tumor extract coeluted on Sephadex G-50 chromatography with rat hypothalamic GH-releasing activity. Stimulation of GH from rat somatotrophs in vitro was achieved at the nanomolar range, using the tumor extract.

The patient's course demonstrates the importance of careful interpretation of pituitary histology. Elevated serum GH and somatomedin C levels in a patient with an enlarged sella turcica and the characteristic responses seen in acromegaly to TRH, dopamine, and glucose do not occur exclusively in patients with discrete pituitary tumors and acromegaly. This condition can also occur with somatotroph hyperplasia and then revert to normal after removal of the GRF source. Thus, in patients with acromegaly a consideration of ectopic GRF secretion should be made, and therefore, careful pituitary histology is mandatory. Consideration for chest and abdominal computer tomographic scans before pituitary surgery, in spite of their low yield, may be justified.

Full text

PDF
965

Images in this article

971Image
on p.971
972Image
on p.972
972Image
on p.972

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arafah B. U., Brodkey J. S., Kaufman B., Velasco M., Manni A., Pearson O. H. Transsphenoidal microsurgery in the treatment of acromegaly and gigantism. J Clin Endocrinol Metab. 1980 Mar;50(3):578–585. doi: 10.1210/jcem-50-3-578. [DOI] [PubMed] [Google Scholar]
  2. BALLARD H. S., FAME B., HARTSOCK R. J. FAMILIAL MULTIPLE ENDOCRINE ADENOMA-PEPTIC ULCER COMPLEX. Medicine (Baltimore) 1964 Jul;43:481–516. [PubMed] [Google Scholar]
  3. BUSE J., BUSE M. G., ROBERTS W. J., Jr Eosinophilic adenoma of the pituitary and carcinoid tumor of the rectosigmoid area. J Clin Endocrinol Metab. 1961 Jun;21:735–738. doi: 10.1210/jcem-21-6-735. [DOI] [PubMed] [Google Scholar]
  4. Bailey P., Davidoff L. M. Concerning the Microscopic Structure of the Hypophysis Cerebri in Acromegaly: (Based on a Study of Tissues Removed at Operation from 35 Patients). Am J Pathol. 1925 Mar;1(2):185–208.19. [PMC free article] [PubMed] [Google Scholar]
  5. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1006/abio.1976.9999. [DOI] [PubMed] [Google Scholar]
  6. Brazeau P., Vale W., Burgus R., Ling N., Butcher M., Rivier J., Guillemin R. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science. 1973 Jan 5;179(4068):77–79. doi: 10.1126/science.179.4068.77. [DOI] [PubMed] [Google Scholar]
  7. Caplan R. H., Koob L., Abellera R. M., Pagliara A. S., Kovacs K., Randall R. V. Cure of acromegaly by operative removal of an islet cell tumor of the pancreas. Am J Med. 1978 May;64(5):874–882. doi: 10.1016/0002-9343(78)90531-4. [DOI] [PubMed] [Google Scholar]
  8. Cronin M. J., Rogol A. D., Dabney L. G., Thorner M. O. Selective growth hormone and cyclic AMP stimulating activity is present in human pancreatic islet cell tumor. J Clin Endocrinol Metab. 1982 Aug;55(2):381–383. doi: 10.1210/jcem-55-2-381. [DOI] [PubMed] [Google Scholar]
  9. DEUBEN R. R., MEITES J. STIMULATION OF PITUITARY GROWTH HORMONE RELEASE BY A HYPOTHALAMIC EXTRACT IN VITRO. Endocrinology. 1964 Mar;74:408–414. doi: 10.1210/endo-74-3-408. [DOI] [PubMed] [Google Scholar]
  10. DI CHIRO G., NELSON K. B. The volume of the sella turcica. Am J Roentgenol Radium Ther Nucl Med. 1962 Jun;87:989–1008. [PubMed] [Google Scholar]
  11. Dabek F. T. Bronchial carcinoid tumour with acromegaly in two patients. J Clin Endocrinol Metab. 1974 Feb;38(2):329–333. doi: 10.1210/jcem-38-2-329. [DOI] [PubMed] [Google Scholar]
  12. Feingold K. R., Goldfine I. D., Weinstein P. R. Acromegaly with normal growth-hormone levels and pituitary histology. Case report. J Neurosurg. 1979 Apr;50(4):503–507. doi: 10.3171/jns.1979.50.4.0503. [DOI] [PubMed] [Google Scholar]
  13. Frohman L. A., Maran J. W., Dhariwal A. P. Plasma growth hormone responses to intrapituitary injections of growth hormone releasing factor (GRF) in the rat. Endocrinology. 1971 Jun;88(6):1483–1488. doi: 10.1210/endo-88-6-1483. [DOI] [PubMed] [Google Scholar]
  14. Frohman L. A., Szabo M., Berelowitz M., Stachura M. E. Partial purification and characterization of a peptide with growth hormone-releasing activity from extrapituitary tumors in patients with acromegaly. J Clin Invest. 1980 Jan;65(1):43–54. doi: 10.1172/JCI109658. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Furlanetto R. W., Underwood L. E., Van Wyk J. J., D'Ercole A. J. Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay. J Clin Invest. 1977 Sep;60(3):648–657. doi: 10.1172/JCI108816. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hoyte K. M., Martin J. B. Recovery from paradoxical growth hormone responses in acromegaly after transphenoidal selective adenomectomy. J Clin Endocrinol Metab. 1975 Oct;41(4):656–659. doi: 10.1210/jcem-41-4-656. [DOI] [PubMed] [Google Scholar]
  17. Johansson K. N., Currie B. L., Folkers K., Bowers C. Y. Identification and purification of factor B-GHRH from hypothalami which releases growth hormone. Biochem Biophys Res Commun. 1974 Sep 23;60(2):610–615. doi: 10.1016/0006-291x(74)90284-8. [DOI] [PubMed] [Google Scholar]
  18. KLAUS H., REINER L., RUSSFIELD A. B. The endocrine significance of hypophyseal tumors in man. Am J Pathol. 1956 Sep-Oct;32(5):1055–1075. [PMC free article] [PubMed] [Google Scholar]
  19. Kovacs K., Horvath E., Ezrin C. Pituitary adenomas. Pathol Annu. 1977;12(Pt 2):341–382. [PubMed] [Google Scholar]
  20. Krulich L., Dhariwal A. P., McCann S. M. Stimulatory and inhibitory effects of purified hypothalamic extracts on growth hormone release from rat pituitary in vitro. Endocrinology. 1968 Oct;83(4):783–790. doi: 10.1210/endo-83-4-783. [DOI] [PubMed] [Google Scholar]
  21. Leveston S. A., McKeel D. W., Jr, Buckley P. J., Deschryver K., Greider M. H., Jaffe B. M., Daughaday W. H. Acromegaly and Cushing's syndrome associated with a foregut carcinoid tumor. J Clin Endocrinol Metab. 1981 Oct;53(4):682–689. doi: 10.1210/jcem-53-4-682. [DOI] [PubMed] [Google Scholar]
  22. Marcovitz S., Goodyer C. G., Guyda H., Gardiner R. J., Hardy J. Comparative study of human fetal, normal adult, and somatotropic adenoma pituitary function in tissue culture. J Clin Endocrinol Metab. 1982 Jan;54(1):6–16. doi: 10.1210/jcem-54-1-6. [DOI] [PubMed] [Google Scholar]
  23. Müller E. E., Liuzzi A., Cocchi D., Panerai A. E., Oppizzi G., Lacatelli V., Mantegazza P., Silvestrini F., Chiodini P. G. Role of dopaminergic receptors in the regulation of growth hormone secretion. Adv Biochem Psychopharmacol. 1977;16:127–138. [PubMed] [Google Scholar]
  24. Nair R. M., deVillier C., Barnes M., Antalis J., Wilbur D. L. A bovine hypothalamic peptide possessing immunoreactive growth hormone-releasing activity. Endocrinology. 1978 Jul;103(1):112–120. doi: 10.1210/endo-103-1-112. [DOI] [PubMed] [Google Scholar]
  25. REICHLIN S. Growth hormone content of pituitaries from rats with hypothalamic lesions. Endocrinology. 1961 Aug;69:225–230. doi: 10.1210/endo-69-2-225. [DOI] [PubMed] [Google Scholar]
  26. SOUTHERN A. L. Functioning metastatic bronchial carcinoid with elevated levels of serum and cerebrospinal fluid serotonin and pituitary adenoma. J Clin Endocrinol Metab. 1960 Feb;20:298–305. doi: 10.1210/jcem-20-2-298. [DOI] [PubMed] [Google Scholar]
  27. Saeed uz Zafar M., Mellinger R. C., Fine G., Szabo M., Frohman L. A. Acromegaly associated with a bronchial carcinoid tumor: evidence for ectopic production of growth hormone-releasing activity. J Clin Endocrinol Metab. 1979 Jan;48(1):66–71. doi: 10.1210/jcem-48-1-66. [DOI] [PubMed] [Google Scholar]
  28. Schnall A. M., Brodkey J. S., Kaufman B., Pearson O. H. Pituitary function after removal of pituitary microadenomas in Cushing's disease. J Clin Endocrinol Metab. 1978 Aug;47(2):410–417. doi: 10.1210/jcem-47-2-410. [DOI] [PubMed] [Google Scholar]
  29. Shalet S. M., Beardwell C. G., MacFarlane I. A., Ellison M. L., Norman C. M., Rees L. H., Hughes M. Acromegaly due to production of a growth hormone releasing factor by a bronchial carcinoid tumor. Clin Endocrinol (Oxf) 1979 Jan;10(1):61–67. doi: 10.1111/j.1365-2265.1979.tb03034.x. [DOI] [PubMed] [Google Scholar]
  30. Sönksen P. H., Ayres A. B., Braimbridge M., Corrin B., Davies D. R., Jeremiah G. M., Oaten S. W., Lowy C., West T. E. Acromegaly caused by pulmonary carcinoid tumours. Clin Endocrinol (Oxf) 1976 Sep;5(5):503–513. doi: 10.1111/j.1365-2265.1976.tb01979.x. [DOI] [PubMed] [Google Scholar]
  31. Takahara J., Arimura A., Schally A. V. Assessment of GH releasing hormone activity in sephadex-separated fractions of porcine hypothalamic extracts by hypophyseal portal vessel infusion in the rat. Acta Endocrinol (Copenh) 1975 Mar;78(3):428–434. doi: 10.1530/acta.0.0780428. [DOI] [PubMed] [Google Scholar]
  32. Tapia F. J., Polak J. M., Barbosa A. J., Bloom S. R., Marangos P. J., Dermody C., Pearse A. G. Neuron-specific enolase is produced by neuroendocrine tumours. Lancet. 1981 Apr 11;1(8224):808–811. doi: 10.1016/s0140-6736(81)92682-9. [DOI] [PubMed] [Google Scholar]
  33. Thorner M. O., Hackett J. T., Murad F., MacLeod R. M. Calcium rather than cyclic AMP as the physiological intracellular regulator of prolactin release. Neuroendocrinology. 1980 Dec;31(6):390–402. doi: 10.1159/000123109. [DOI] [PubMed] [Google Scholar]
  34. Thorner M. O., Martin W. H., Rogol A. D., Morris J. L., Perryman R. L., Conway B. P., Howards S. S., Wolfman M. G., MacLeod R. M. Rapid regression of pituitary prolactinomas during bromocriptine treatment. J Clin Endocrinol Metab. 1980 Sep;51(3):438–445. doi: 10.1210/jcem-51-3-438. [DOI] [PubMed] [Google Scholar]
  35. Vale W., Grant G., Amoss M., Blackwell R., Guillemin R. Culture of enzymatically dispersed pituitary cells: functional validation of a method. Endocrinology. 1972 Aug;91(2):562–572. doi: 10.1210/endo-91-2-562. [DOI] [PubMed] [Google Scholar]
  36. WEISS L., INGRAM M. Adenomatoid bronchial tumors. A consideration of the carcinoid tumors and the salivary tumors of the bronchial tree. Cancer. 1961 Jan-Feb;14:161–178. doi: 10.1002/1097-0142(196101/02)14:1<161::aid-cncr2820140120>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  37. WILLEMSE C. H. A patient suffering from Turner's syndrome and acromegaly. Acta Endocrinol (Copenh) 1962 Feb;39:204–212. doi: 10.1530/acta.0.0390204. [DOI] [PubMed] [Google Scholar]
  38. Wilber J. F., Nagel T., White W. F. Hypothalamic growth hormone releasing activity (GRA): characterization by the in vitro rat pituitary and radioimmunoassay. Endocrinology. 1971 Dec;89(6):1419–1424. doi: 10.1210/endo-89-6-1419. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES